The global transcriptome sequencing market is projected to reach $11.8 billion by 2035, growing at a 7.3% CAGR from 2025 to 2035. Growth is driven by falling sequencing costs, precision medicine, drug ...

Former Kim lab postdoctoral scholar Sreelakshmi Velandi Maroli and Ph.D. student Connor Mattingly work in the lab. Esophageal cancer, which is cancer of the swallowing tube, has only a 22.2% five-year ...

Salivary gland cancers (SGCs) are rare and comprise multiple histologic entities. In the recurrent or metastatic (R/M) setting, there is limited evidence for effective systemic anticancer treatment ...

A new RNA search engine can scan millions of cells in seconds for mutations, pathogens, isoforms and other biological clues.

Every cancer carries a unique genetic fingerprint: variations in DNA known as “somatic variants” that occur in tumor DNA but are absent from the patient’s healthy cells. While some cancers may also ...

Prediction of Anthracycline Benefit in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Early-Stage Breast Cancer by the MammaPrint 70-Gene Signature for Patients Enrolled ...

Hiroshima University researchers have developed a practical framework to identify candidate pathogenic variants hidden among the large number of variants of uncertain significance (VUS) detected in ...

Imagine doctors could understand exactly which cells caused a patient's cancer or whether pathogens contributed to the ...

LAUSANNE, Switzerland--(BUSINESS WIRE)--Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced today the closing of its seed financing round ...